Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma
Open Access
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Oral Glucocorticoid–Sparing Effect of Benralizumab in Severe AsthmaNew England Journal of Medicine, 2017
- Commonality of the IL-4/IL-13 pathway in atopic diseasesExpert Review of Clinical Immunology, 2017
- Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohortEuropean Respiratory Journal, 2015
- Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic AsthmaNew England Journal of Medicine, 2014
- Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal miceProceedings of the National Academy of Sciences, 2014
- Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genesProceedings of the National Academy of Sciences, 2014
- Dose-related patterns of glucocorticoid-induced side effectsAnnals of the Rheumatic Diseases, 2009
- Severe Exacerbations and Decline in Lung Function in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Airway remodeling and lack of bronchodilator response in steroid-resistant asthmaJournal of Allergy and Clinical Immunology, 2007
- Oral corticosteroid-sparing effects of inhaled corticosteroids in the treatment of persistent and acute asthmaAnnals of Allergy, Asthma & Immunology, 2004